Walleye Trading LLC Sarepta Therapeutics, Inc. Put Options Transaction History

Walleye Trading LLC

$46.7 Billion
Q3 2024

Put Options

24 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$124.33 - $156.75 $5.05 Million - $6.36 Million	-40,600 Reduced 92.27%	3,400 $424,000
Q2 2024 Aug 14, 2024	BUY	$113.33 - $163.85 $3.06 Million - $4.42 Million	27,000 Added 158.82%	44,000 $6.95 Million
Q1 2024 May 15, 2024	SELL	$93.7 - $141.53 $768,340 - $1.16 Million	-8,200 Reduced 32.54%	17,000 $2.2 Million
Q4 2023 Feb 14, 2024	SELL	$67.31 - $124.76 $1.53 Million - $2.83 Million	-22,700 Reduced 47.39%	25,200 $2.43 Million
Q3 2023 Nov 14, 2023	BUY	$102.5 - $123.59 $973,750 - $1.17 Million	9,500 Added 24.74%	47,900 $5.81 Million
Q2 2023 Aug 14, 2023	SELL	$106.4 - $157.19 $12 Million - $17.7 Million	-112,800 Reduced 74.6%	38,400 $4.4 Million
Q1 2023 May 15, 2023	BUY	$117.53 - $155.99 $8.02 Million - $10.6 Million	68,200 Added 82.17%	151,200 $20.8 Million
Q4 2022 Feb 14, 2023	SELL	$100.86 - $132.13 $262,236 - $343,538	-2,600 Reduced 3.04%	83,000 $10.8 Million
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $6.48 Million - $10.2 Million	85,600 New	85,600 $9.46 Million
Q1 2022 May 16, 2022	SELL	$63.15 - $90.42 $88,410 - $126,588	-1,400 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$77.28 - $99.42 $780,528 - $1 Million	-10,100 Reduced 87.83%	1,400 $126,000
Q3 2021 Nov 15, 2021	SELL	$65.97 - $92.48 $877,401 - $1.23 Million	-13,300 Reduced 53.63%	11,500 $1.06 Million
Q2 2021 Aug 16, 2021	BUY	$69.38 - $86.75 $1.31 Million - $1.64 Million	18,900 Added 320.34%	24,800 $1.93 Million
Q1 2021 May 17, 2021	BUY	$72.25 - $168.95 $419,050 - $979,909	5,800 Added 5800.0%	5,900 $440,000
Q4 2020 Feb 16, 2021	SELL	$125.56 - $178.74 $276,232 - $393,228	-2,200 Reduced 95.65%	100 $17,000
Q3 2020 Nov 16, 2020	BUY	$127.12 - $172.34 $12,712 - $17,234	100 Added 4.55%	2,300 $323,000
Q2 2020 Aug 14, 2020	SELL	$93.0 - $171.7 $1.82 Million - $3.37 Million	-19,600 Reduced 89.91%	2,200 $353,000
Q1 2020 May 15, 2020	BUY	$82.38 - $131.64 $1.65 Million - $2.63 Million	20,000 Added 1111.11%	21,800 $2.13 Million
Q4 2019 Feb 14, 2020	BUY	$76.53 - $135.58 $99,489 - $176,254	1,300 Added 260.0%	1,800 $232,000
Q3 2019 Nov 14, 2019	SELL	$72.81 - $156.91 $116,496 - $251,056	-1,600 Reduced 76.19%	500 $38,000
Q1 2019 May 15, 2019	SELL	$106.67 - $151.68 $32,001 - $45,504	-300 Reduced 12.5%	2,100 $250,000
Q4 2018 Feb 14, 2019	SELL	$97.32 - $148.76 $68,124 - $104,132	-700 Reduced 22.58%	2,400 $262,000
Q3 2018 Nov 14, 2018	BUY	$115.31 - $161.51 $311,337 - $436,077	2,700 Added 675.0%	3,100 $501,000
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $28,695 - $61,476	400 New	400 $53,000

Others Institutions Holding SRPT

# of Institutions

528

Shares Held

83.9M

Call Options Held

2.06M

Put Options Held

1.52M

Black Rock Inc. New York, NY

10.3M
Shares

$1.2 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

8.97M
Shares

$1.04 Billion
0.02% of portfolio
Capital International Investors Los Angeles, CA

6.26M
Shares

$727 Million
0.16% of portfolio
Janus Henderson Group PLC London, X0

4.36M
Shares

$506 Million
0.29% of portfolio
State Street Corp Boston, MA

4.27M
Shares

$496 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.2B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account